Last reviewed · How we verify

NCT05078346

Immune Fitness Prediction

Completed Last updated 4 February 2022
What this trial tests

trial in Healthy Adults in 90 participants. Completed in 3 February 2022.

Timeline
2 June 2021
Primary endpoint
28 January 2022
3 February 2022

Quick facts

Lead sponsorSociété des Produits Nestlé (SPN)
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date2 June 2021
Primary completion28 January 2022
Estimated completion3 February 2022
Sites1 location across Switzerland

Conditions studied

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 35 to 65, any sex, with Healthy Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of the study is to determine whether self-rated, perceived immune fitness (using questionnaire) is associated with biological assessment of immune fitness (immune signatures in the blood).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Adults

Currently open trials in the same condition.

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05078346.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing